Peptides DB
Research-centric peptide and protocol reference hub
Study 16 of 57HCG (Human Chorionic Gonadotropin) literaturebiorxiv-preprint · Animal study2026

Male fertility is independent of Enh13 control of Sox9 testicular expression

Enh13 is essential for starting the male development pathway but not for maintaining male fertility after sex determination in mice.

Read at biorxiv-preprintAdd to compare

Where it sits

this study against the rest of the hcg (human chorionic gonadotropin) corpus
9
Preclinical · this one
43
Observational
0
Open-label
3
Randomised
2
Reviews

Summary and findings

This study investigates the role of the Enh13 enhancer in the regulation of Sox9 expression during testis development in mice. It examines the effects of Enh13 deletion at different developmental stages on male fertility and testis architecture. The findings indicate that Enh13 is critical for initiating the male pathway but not for maintaining fertility post-sex determination.

How much of this paper we could read: full text read (0.70). We had a clear abstract, so the summary below closely tracks the paper. What this means →
Not reported in abstract.2026

Abstract

The authors’ words, as biorxiv-preprint supplied them

Testis development relies on precise temporal control of Sox9 expression, which is rapidly activated to initiate testis development and subsequently maintained to preserve Sertoli cell identity and male fertility. The distal enhancer, Enh13, is essential for Sox9 upregulation as its constitutive deletion results in complete XY male-to-female sex reversal. Enh13’s requirement across distinct developmental stages remains unexplored. We show that early gonadal deletion of Enh13 fully recapitulates XY sex reversal, demonstrating that Enh13 activity is strictly required to initiate the male pathway. In contrast, Sertoli cell-specific deletion of Enh13 after sex determination has no effect on Sox9 expression, testis architecture, or male fertility, revealing that Enh13 is dispensable for Sox9 maintenance in the differentiated testis. Chromatin accessibility identifies candidate enhancers gaining activity after sex determination, suggesting a regulatory handoff within the Sox9 locus. Finally, we show that duplicating Enh13 in the endogenous mouse locus fails to recapitulate the human XX sex reversal, suggesting that it may not be solely Enh13 sequence duplication that led to XX sex reversal in humans. To the best of our knowledge, this study represents the first in vivo conditional knockout of a developmental enhancer, allowing for temporally controlled interrogation of regulatory logic.

Elsewhere in the HCG (Human Chorionic Gonadotropin) corpus

BHigh-intensity focused ultrasound as a bridging vascular-modulating therapy for fertility-sparing management of placental site trophoblastic tumor complicated by uterine arteriovenous fistula: a case report.International journal of hyperthermia : the official journal of European Society for Hyperthermic Oncology, North American Hyperthermia Group · 2026 · n=1 · Not reported in abstract.HumanBHigh-intensity focused ultrasound as a bridging vascular-modulating therapy for fertility-sparing management of placental site trophoblastic tumor complicated by uterine arteriovenous fistula: a case report.International journal of hyperthermia : the official journal of European Society for Hyperthermic Oncology, North American Hyperthermia Group · 2026 · Not reported in abstract.HumanBCombined ovarian tissue cryopreservation and in vitro maturation of ovarian- tissue oocytes (OTO-IVM) for emergency fertility preservation in the early postpartum period: a case report and systematic review of the literaturebiorxiv-preprint · 2023 · n=1 · Prolactin was 504.8 mIU/L.HumanBPrediction of Preterm Birth Using the Second-Trimester Quadruple Testbiorxiv-preprint · 2026 · n=200 · AUC of 0.747 for the four-marker model.HumanBRedefining "Normal" for hCG in postmenopausal women: 97.5th percentile reference intervals and 99th percentile thresholds across four chemiluminescence immunoassay systems.Clinica chimica acta; international journal of clinical chemistry · 2026 · n=460 · 97.5th percentile RIs were <7.1, <8.2, <5.7, and <5.9 IU/L for Systems A-D.HumanBCase reports of old ectopic pregnancies with intrauterine devicesbiorxiv-preprint · 2026 · Not reported in abstract.Human